C12N 2795/10221
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2795/10221 (Viruses as such) appears on 52 US grants and 75 published applications in this corpus.
Search patents in C12N- Granted patents
- 52
- Published applications
- 75
- Assignees
- 39
- Inventors
- 131
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 3 |
| 2015 | 0 | 3 |
| 2016 | 2 | 8 |
| 2017 | 2 | 5 |
| 2018 | 4 | 6 |
| 2019 | 10 | 9 |
| 2020 | 6 | 4 |
| 2021 | 7 | 6 |
| 2022 | 2 | 6 |
| 2023 | 6 | 4 |
| 2024 | 7 | 9 |
| 2025 | 2 | 3 |
| 2026 | 3 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Bacteriophage, bacterial wilt disease control agent, and bacterial wilt disease control method14 Apr 2026US 12,599,142 B2Panefri Industrial Co., Ltd.
- Bacteriophage compositions for treating Pseudomonas infection7 Apr 2026US 12,594,312 B2Armata Pharmaceuticals, Inc.
- Bacteriophage for modulating inflammatory bowel disease19 Aug 2025US 12,390,499 B2Biomx Ltd.
- Crispr-CAS10 systems and methods for phage genome editing5 Aug 2025US 12,378,577 B2The Board of Trustees of The University of Alabama
- Bacteriophages and use thereof for the treatment or prevention of infection caused by salmonella gallinarum23 Jul 2026US 2026/0207687 A1Purdue Research Foundation
- Crop treatment16 Jul 2026US 2026/0198510 A1APS Biocontrol Limited
- Staphylococcus phage compositions and cocktails thereof7 May 2026US 2026/0124259 A1Locus Biosciences, Inc.
- Bacteriophage compositions and methods for treatment of bacterial infections23 Apr 2026US 2026/0108570 A1The University of Chicago
- Simultaneous production of structural proteins from heterologous bacteriophage in cell-free expression system2 Apr 2026US 2026/0092261 A1Technische Universität München
Most cited
By later US patents
- Engineered enzymatically active bacteriophage and methods for dispersing biofilms20US 8,153,119 B2Massachusetts Institute of Technology · 2012
- Methods and systems for rapid detection of microorganisms using infectious agents9US 10,519,483 B2Laboratory Corporation of America Holdings · 2019
- Phage therapy of pseudomonas infections6US 10,077,431 B2Pherecydes Pharma · 2018
- Method for treatment and control of plant disease5US 9,357,785 B2The Texas A&M University System · 2016
- Method for treatment and control of plant disease4US 10,499,651 B2The Texas A&M University System · 2019